Word: drugged
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...Chicago the Food and Drug Administration, acknowledging growing public concern, held the first of three public forums on g.m. foods. FrankenTony showed up, along with a covey of kids dressed as monarch butterflies, feigning death before a mock cornstalk--an allusion to the discovery by scientists last spring that, at least in the lab, pollen from g.m. corn can kill the butterfly's caterpillars. Not to be left out, Secretary of Agriculture Dan Glickman was said to be considering the appointment of a panel of experts to advise him on the pros and cons of biotech. And in the surest...
...laundry. This enthusiasm was both his greatest strength and perhaps his fatal flaw. If on the job he channeled that eagerness into getting a client interested in a new script or a studio in a project, in treatment he pumped his fist about how great it felt to be drug free. He was always, consummately, in the moment. And for him, there had been some pretty hairy moments. He had begun doing cocaine about six months before, and in a pattern familiar to most addicts had gradually been increasing his consumption until he was ingesting nearly fatal doses. Desperate...
...folks, Levy had never heard of macular degeneration. Unlike most, she was in a position to do something about it. One of the co-founders of a biotech company called QLT PhotoTherapeutics, Levy worked with David Dolphin of the University of British Columbia to develop Visudyne, a drug that uses light rays to combat the severest form of the disease. Although their research couldn't help Levy's mother, who died in 1996, it has passed muster with a scientific advisory panel to the U.S. Food and Drug Administration. Last week the panel recommended that the FDA approve Visudyne...
...exciting as the news about Visudyne is, there are some important caveats to bear in mind. The drug is not a cure. At best, it preserves the status quo. It will not restore vision that has already been lost. Nor does it work for everyone. Company officials estimate that only one-quarter to one-half of the 200,000 or so Americans who develop the severest form of macular degeneration each year will benefit. But for them, it could be the window on the world that allows them to maintain their independence...
Visudyne works only on wet macular degeneration, and produces the best results in patients whose retinal abnormalities occur mostly in what is known as the classic pattern. Doctors inject the drug into a vein in the patient's arm; from there it quickly spreads through the body. The drug concentrates wherever new blood vessels are being formed. But it doesn't start destroying those blood vessels until it is activated by pulses of light from a non-heat-generating laser. Since the light is shone into the eye, only the abnormal growths in the retina are targeted. Patients have...